Switching From Protease Inhibitor/Ritonavir to Generic Single Tablet Regimen of Tenofovir Alafenamide/Emtricitibine/Dolutegravir
Clinical trial NCT03727152 · COMPLETED
Trial details
- NCT number
- NCT03727152
- Sponsor
- The HIV Netherlands Australia Thailand Research Collaboration
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2023-04-04
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.